Sæbø IP, Dyhr E, Riisnæs IMM, Franzyk H, Bjørås M, Booth JA, Helgesen E(2025) Rational design of synthetic antimicrobial peptides based on the Escherichia coli ShoB toxin Sci Rep, 15(1), 14354 DOI 10.1038/s41598-025-98330-3, PubMed 40274891
Lobie TA, Krog CS, Skarstad K, Bjørås M, Booth JA(2025) Escherichia coli type I toxin TisB exclusively controls proton depolarization following antibiotic induced DNA damage Sci Rep, 15(1), 12774 DOI 10.1038/s41598-025-96136-x, PubMed 40229382
Matar S, Skah S, Diomande LE, Buss T, Hagland HR, Yadav A, Forstrøm RJ, Dalhus B, Hestdal K, Pettersen RD, Richartz N(2025) Development of a novel bifunctional anti-CD47 fusion protein with improved efficacy and a favorable safety profile Mol Cancer Ther(in press) DOI 10.1158/1535-7163.MCT-24-0917, PubMed 40084615
Professor Magnar Bjørås, Department of Microbiology Oslo University Hospital Rikshospitalet PO Box 4950 Nydalen NO-0424 Oslo, Norway Tel: +47 23074059, E-mail: magnar.bjoras@ntnu.no / magnar.bjoras@medisin.uio.no
